Needle Length May Affect Vaccination Results in Obese

HBV study in young adults supports link between lower muscle penetration and immune response
By Eric Metcalf
HealthDay Reporter

TUESDAY, Feb. 9 (HealthDay News) -- The reduced immune response seen in obese adolescents and adults following hepatitis B virus (HBV) vaccination may be due in part to insufficient needle penetration of muscle, according to research published online Feb. 8 in Pediatrics.

Amy B. Middleman, M.D., of the Baylor College of Medicine in Houston, and colleagues analyzed data from 24 teens and young adults, aged 14 to 24 years. Females weighed more than 90 kg and males more than 120 kg. Subjects were randomized to receive their HBV vaccination series with a 1- or 1.5-inch needle.

The researchers found that subjects vaccinated with a 1.5-inch needle had significantly higher antibody titers to HBV surface antigen compared to the 1-inch-needle group (345.4 versus 189.8 mIU/mL).

"Despite the small sample size, obese adolescents and young adults achieved significantly higher titers of anti-HBs after HBV vaccine when a 1.5-inch needle was used for administration rather than a 1-inch needle. This supports the hypothesis that inadequate muscle penetration is responsible, at least in part, for lower immune response to HBV vaccine among obese adolescent and adult vaccine recipients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2010 HealthDay. All rights reserved.

Powered by

Featured Jobs



Benefits of Membership

FREE E-Newsletters
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues

CESaver
Join our CESaver program to earn up to 100 contact hours for only $34.95
Register Now

Lippincott's NursingCenter.com
Explore a world of online resources

Become a Member